ProMIS Neurosciences appoints Neil Warma as interim CEO after Gail Farfel departure

ProMIS Neurosciences Inc.

CEO Gail Farfel separated as President/CEO and Board member effective Dec 30, 2023; will receive severance per agreement.
Neil Warma appointed interim CEO effective Dec 30, 2023; continues as Board member.
Compensation: $250k base salary, up to $400k milestone bonus, and options for 200k shares.
Warma brings neuroscience background; company plans to advance PMN310 in Alzheimer's and seek partnerships.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Neil Warma

President and interim Chief Executive Officer

PMN · ProMIS Neurosciences Inc.

Effective: 2023-12-30
Filed: January 3, 2024, 6:59 PM ET

Effective December 30, 2023, the Board appointed Neil Warma as President and interim Chief Executive Officer and principal executive officer of the Company (the “Appointment”).

Departed

Gail Farfel

President and Chief Executive Officer

PMN · ProMIS Neurosciences Inc.

Effective: 2023-12-30
Successor: Neil Warma
Filed: January 3, 2024, 6:59 PM ET

it separated with Gail Farfel, Ph.D. as President and Chief Executive Officer and principal executive officer of the Company, and as a member of the Board of Directors of the Company (the “Board”), in each case, effective as of December 30, 2023

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Neil Warma was appointed as President and interim Chief Executive Officer at ProMIS Neurosciences Inc..

Action: appointed
Role: President and interim Chief Executive Officer

Exact text from the filing

Effective December 30, 2023, the Board appointed Neil Warma as President and interim Chief Executive Officer and principal executive officer of the Company (the “Appointment”).

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Gail Farfel departed as President and Chief Executive Officer at ProMIS Neurosciences Inc..

Action: separated
Role: President and Chief Executive Officer

Exact text from the filing

it separated with Gail Farfel, Ph.D. as President and Chief Executive Officer and principal executive officer of the Company, and as a member of the Board of Directors of the Company (the “Board”), in each case, effective as of December 30, 2023

View on SEC.gov

ProMIS Neurosciences Inc. filing history →

Source: SEC EDGAR

accession 0001558370-24-000021

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.